Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 23855303)

1.

Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?

Yi HS, Jeong WI.

J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:99-104. doi: 10.1111/jgh.12017. Review.

PMID:
23855303
2.

CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice.

Suh YG, Kim JK, Byun JS, Yi HS, Lee YS, Eun HS, Kim SY, Han KH, Lee KS, Duester G, Friedman SL, Jeong WI.

Hepatology. 2012 Nov;56(5):1902-12. doi: 10.1002/hep.25817. Epub 2012 Oct 9.

3.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
4.

Macrophages: master regulators of inflammation and fibrosis.

Wynn TA, Barron L.

Semin Liver Dis. 2010 Aug;30(3):245-57. doi: 10.1055/s-0030-1255354. Epub 2010 Jul 21. Review.

5.

IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells.

Preisser L, Miot C, Le Guillou-Guillemette H, Beaumont E, Foucher ED, Garo E, Blanchard S, Frémaux I, Croué A, Fouchard I, Lunel-Fabiani F, Boursier J, Roingeard P, Calès P, Delneste Y, Jeannin P.

Hepatology. 2014 Dec;60(6):1879-90. doi: 10.1002/hep.27328. Epub 2014 Oct 29.

PMID:
25066464
6.

Cell death and fibrogenesis.

Mehal W, Imaeda A.

Semin Liver Dis. 2010 Aug;30(3):226-31. doi: 10.1055/s-0030-1255352. Epub 2010 Jul 21. Review.

7.

Monocytes and macrophages as cellular targets in liver fibrosis.

Heymann F, Trautwein C, Tacke F.

Inflamm Allergy Drug Targets. 2009 Sep;8(4):307-18. Review.

PMID:
19534673
8.

Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.

Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F.

Hepatology. 2009 Jul;50(1):261-74. doi: 10.1002/hep.22950.

PMID:
19554540
9.

Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Elpek GÖ.

World J Gastroenterol. 2014 Jun 21;20(23):7260-76. doi: 10.3748/wjg.v20.i23.7260. Review.

10.

Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type.

Langhans B, Alwan AW, Krämer B, Glässner A, Lutz P, Strassburg CP, Nattermann J, Spengler U.

J Hepatol. 2015 Feb;62(2):398-404. doi: 10.1016/j.jhep.2014.08.038. Epub 2014 Sep 6.

PMID:
25195554
11.

Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis.

Zhao Q, Qin CY, Zhao ZH, Fan YC, Wang K.

Tohoku J Exp Med. 2013;229(1):35-43. Review.

12.

Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.

Knight V, Tchongue J, Lourensz D, Tipping P, Sievert W.

Hepatology. 2012 Mar;55(3):879-87. doi: 10.1002/hep.24784. Epub 2012 Jan 12.

PMID:
22095855
13.

Cytokine regulation of hepatic stellate cells in liver fibrosis.

Tsukamoto H.

Alcohol Clin Exp Res. 1999 May;23(5):911-6. Review.

PMID:
10371413
14.

Hepatic stellate cells as a target for the treatment of liver fibrosis.

Bataller R, Brenner DA.

Semin Liver Dis. 2001 Aug;21(3):437-51. Review.

PMID:
11586471
15.

Interleukin-1 participates in the progression from liver injury to fibrosis.

Gieling RG, Wallace K, Han YP.

Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1324-31. doi: 10.1152/ajpgi.90564.2008. Epub 2009 Apr 2.

16.

Retinoic acids and hepatic stellate cells in liver disease.

Lee YS, Jeong WI.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:75-9. doi: 10.1111/j.1440-1746.2011.07007.x. Review.

PMID:
22320921
17.

Liver fibrosis: mechanisms of immune-mediated liver injury.

Xu R, Zhang Z, Wang FS.

Cell Mol Immunol. 2012 Jul;9(4):296-301. doi: 10.1038/cmi.2011.53. Epub 2011 Dec 12. Review.

18.

Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.

Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, Cong M, Iwaisako K, Liu X, Zhang M, Osterreicher CH, Stickel F, Ley K, Brenner DA, Kisseleva T.

Gastroenterology. 2012 Sep;143(3):765-76.e1-3. doi: 10.1053/j.gastro.2012.05.049. Epub 2012 Jun 8.

19.

Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages.

Olaso E, Arteta B, Benedicto A, Crende O, Friedman SL.

Am J Pathol. 2011 Dec;179(6):2894-904. doi: 10.1016/j.ajpath.2011.09.002. Epub 2011 Oct 19.

20.

Liver fibrosis - mouse models and relevance in human liver diseases.

Mederacke I.

Z Gastroenterol. 2013 Jan;51(1):55-62. doi: 10.1055/s-0032-1330422. Epub 2013 Jan 11.

PMID:
23315652
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk